Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis
Clinical trial NCT03250624 · COMPLETED
Trial details
- NCT number
- NCT03250624
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-06-26
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.